A detailed history of Platinum Investment Management LTD transactions in Allakos Inc. stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,172,061 shares of ALLK stock, worth $984,531. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,172,061
Previous 635,023 84.57%
Holding current value
$984,531
Previous $1.73 Million 14.83%
% of portfolio
0.06%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.02 - $3.23 $547,778 - $1.73 Million
537,038 Added 84.57%
1,172,061 $1.48 Million
Q1 2023

May 11, 2023

BUY
$4.3 - $8.27 $1.01 Million - $1.94 Million
234,579 Added 58.58%
635,023 $2.83 Million
Q4 2022

Feb 13, 2023

BUY
$5.97 - $8.42 $2.39 Million - $3.37 Million
400,444 New
400,444 $3.37 Million

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $71.2M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.